MORGAN STANLEY

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 895421 NEW YORK, NY

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$268,542,463

+$6,256,581 QoQ

Shares Held

833,491

-6.3% QoQ

Ownership

2.99%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 98.64641609807424.ToString("F0")% Shared 0.ToString("F0")% None 1.3535839019257556.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. PRAX ranks #11 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$268,542,463	833,491	-6.3%	Shares	Defined	2026-05-15
2025-12-31	$262,285,882	889,889	+38.3%	Shares	Defined	2026-05-27
2025-09-30	$34,105,235	643,495	-47.5%	Shares	Defined	2026-05-27
2025-06-30	$51,567,552	1,226,339	+1.0%	Shares	Defined	2025-08-15
2025-03-31	$45,961,642	1,213,669	+4.3%	Shares	Defined	2025-05-15
2024-12-31	$89,544,958	1,163,526	+1345.4%	Shares	Defined	2025-05-15
2024-09-30	$4,631,967	80,500	-56.3%	Shares	Defined	2025-05-14
2024-06-30	$7,623,430	184,319	+84.1%	Shares	Defined	2025-05-14
2024-03-31	$6,110,296	100,136	+491.4%	Shares	Defined	2024-10-17
2023-12-31	$377,266	16,933	—	Shares	Defined	2024-08-16
No filing history on record for this holder in this stock.